Review Article Nirsevimab for RSV Prevention in India: Economic Viability and Implementation Pathways for National Introduction: A Review Gaurav Gupta J Vac Immuno 1 (1) (24th September, 2026) DOI: 10.25259/JVI_2_2026 Full text | PDF
PDF